scholarly article | Q13442814 |
P2093 | author name string | Lawrence R Lustig | |
Omar Akil | |||
Dylan K Chan | |||
Stephanie L Rouse | |||
P2860 | cites work | Structure of Adeno-Associated Virus Serotype 8, a Gene Therapy Vector | Q27647639 |
Sensorineural deafness and seizures in mice lacking vesicular glutamate transporter 3. | Q27863377 | ||
Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics | Q28141424 | ||
Vesicular glutamate transporters 1 and 2 target to functionally distinct synaptic release sites | Q28589089 | ||
Adenovector-mediated hair cell regeneration is affected by promoter type. | Q30364969 | ||
Gene therapy in the inner ear using adenovirus vectors | Q30409346 | ||
Gene transfer in human vestibular epithelia and the prospects for inner ear gene therapy | Q30440245 | ||
Gene therapy and stem cell transplantation: strategies for hearing restoration | Q30448504 | ||
Restoration of hearing in the VGLUT3 knockout mouse using virally mediated gene therapy. | Q30451780 | ||
Inner ear gene transfection in neonatal mice using adeno-associated viral vector: a comparison of two approaches | Q30464591 | ||
Adeno-associated virus-mediated gene delivery into the scala media of the normal and deafened adult mouse ear. | Q30472510 | ||
Targeted ablation of connexin26 in the inner ear epithelial gap junction network causes hearing impairment and cell death | Q30578611 | ||
Kv7-type channel currents in spiral ganglion neurons: involvement in sensorineural hearing loss | Q34251255 | ||
Auditory hair cell replacement and hearing improvement by Atoh1 gene therapy in deaf mammals | Q34394494 | ||
The role of connexins in human disease. | Q35201418 | ||
Mouse models to study inner ear development and hereditary hearing loss | Q36950147 | ||
Gap junctions and connexins in the inner ear: their roles in homeostasis and deafness | Q37271371 | ||
Mouse models for human hereditary deafness | Q37383087 | ||
Cellular targeting for cochlear gene therapy | Q37507101 | ||
Hearing loss: mechanisms revealed by genetics and cell biology | Q37582921 | ||
How the genetics of deafness illuminates auditory physiology | Q37809076 | ||
Mouse Cochlear Whole Mount Immunofluorescence | Q39467632 | ||
A surgical approach appropriate for targeted cochlear gene therapy in the mouse | Q40734130 | ||
Green fluorescent protein as a reporter for gene transfer studies in the cochlea | Q40871576 | ||
Development of in vivo gene therapy for hearing disorders: introduction of adeno-associated virus into the cochlea of the guinea pig. | Q40934948 | ||
Adenoviral vectors for improved gene delivery to the inner ear. | Q42109130 | ||
Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain | Q42280576 | ||
Hearing preservation after inner ear gene therapy: the effect of vector and surgical approach. | Q42451504 | ||
Gene transfer into guinea pig cochlea using adeno-associated virus vectors | Q42525743 | ||
Long-term in vivo cochlear transgene expression mediated by recombinant adeno-associated virus | Q44136141 | ||
Efficient and specific transduction of cochlear supporting cells by adeno-associated virus serotype 5. | Q44705948 | ||
The functional and structural outcome of inner ear gene transfer via the vestibular and cochlear fluids in mice | Q45071652 | ||
Noninvasive in vivo delivery of transgene via adeno-associated virus into supporting cells of the neonatal mouse cochlea | Q45395514 | ||
The effect of cochleostomy and intracochlear infusion on auditory brain stem response threshold in the guinea pig. | Q45855751 | ||
Inner ear transgene expression after adenoviral vector inoculation in the endolymphatic sac. | Q45857676 | ||
AAV-mediated delivery of the caspase inhibitor XIAP protects against cisplatin ototoxicity | Q45859205 | ||
Viral-mediated gene transfer in the cochlea | Q45883103 | ||
Cochlear microinjection and its effects upon auditory function in the guinea pig. | Q46100531 | ||
Progressive deafness and altered cochlear innervation in knock-out mice lacking prosaposin. | Q46425316 | ||
Cochlear gene delivery through an intact round window membrane in mouse | Q46630707 | ||
Adenoviral-mediated gene transfer into guinea pig cochlear cells in vivo. | Q50515400 | ||
Interaction of cisplatin and noise on the peripheral auditory system. | Q50548304 | ||
P433 | issue | 97 | |
P407 | language of work or name | English | Q1860 |
P577 | publication date | 2015-03-16 | |
P1433 | published in | Journal of Visualized Experiments | Q954500 |
P1476 | title | Surgical method for virally mediated gene delivery to the mouse inner ear through the round window membrane |
Q52649043 | A Surgical Procedure for the Administration of Drugs to the Inner Ear in a Non-Human Primate Common Marmoset (Callithrix jacchus). |
Q61118468 | AAV2.7m8 is a powerful viral vector for inner ear gene therapy |
Q64986345 | Anatomical and Surgical Evaluation of the Common Marmoset as an Animal Model in Hearing Research. |
Q93016803 | Antisense Oligonucleotides for the Treatment of Inner Ear Dysfunction |
Q59359281 | Canalostomy As a Surgical Approach to Local Drug Delivery into the Inner Ears of Adult and Neonatal Mice |
Q38783334 | Challenges for the application of optical stimulation in the cochlea for the study and treatment of hearing loss |
Q30359095 | Cochlear gene therapy with ancestral AAV in adult mice: complete transduction of inner hair cells without cochlear dysfunction. |
Q90505891 | Genetic Therapies for Hearing Loss: Accomplishments and Remaining Challenges |
Q45863463 | Hearing Loss after Round Window Surgery in Mice Is due to Middle Ear Effusion. |
Q50312575 | It's All in the Delivery: Improving AAV Transfection Efficiency with Exosomes |
Q36413770 | Rhesus Cochlear and Vestibular Functions Are Preserved After Inner Ear Injection of Saline Volume Sufficient for Gene Therapy Delivery |
Q92127585 | Viral Transfer of Mini-Otoferlins Partially Restores the Fast Component of Exocytosis and Uncovers Ultrafast Endocytosis in Auditory Hair Cells of Otoferlin Knock-Out Mice |
Q59353271 | Virally Mediated Overexpression of Glial-Derived Neurotrophic Factor Elicits Age- and Dose-Dependent Neuronal Toxicity and Hearing Loss |
Search more.